3rd GLP-1-Based Therapeutics Summit 2026
Meet
Nick Maragos
VP – Business Development
Nitin Mittal
AVP – Business Development
at our booth
Join the session:
Enabling GLP-1 Commercial Success through Drug–Device Readiness
- Drug–device readiness is a commercial differentiator for GLP-1s
- Integrated formulation–DP–device approach reduces risk and timelines
- Early device strategy enables scalable growth